Aktie A1XEQX PROTEXT MOBILITY, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen ProText Mobility, Inc.

Aktien

A1XEQX

US74371E2046

TXTM

Verzögert OTC Markets
Andere Börsenplätze
 16:31:37 19.04.2024 		% 5 Tage % 1. Jan.
0,002 USD +8,70 % Intraday Chart für ProText Mobility, Inc. -20,00 % +17,65 %
2022 Protext Mobility, Inc. und RSAMMDA LLC stellen das Shareholder Update zur Verfügung CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended
ProText Mobility : Quarterly Report
ProText Mobility : Notification of Late Filing
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1XEQX Aktie
  4. Nachrichten ProText Mobility, Inc.
  5. Andere Sprachen